Department of Ophthalmology and Visual Science, Seoul St. Mary's Hospital, College of Medicine, The Catholic University of Korea, 222 Banpo-daero, Seocho-gu, Seoul, 06591, South Korea.
BMC Ophthalmol. 2020 Jan 13;20(1):24. doi: 10.1186/s12886-019-1301-0.
Radiation therapy (RT) is the treatment of choice in patients with low-grade ocular adenexal mucosa-associated lymphoid tissue lymphoma (OAML) and many of them experience post-RT dry eye with varying severity. The purpose of the present study was to investigate ocular effects of RT on meibomian glands and dry eye by directly visualizing structural changes. Secondly, we focused on the comparison of two groups of patients according to tumor location and radiation technique.
Sixty-four eyes with OAML of conjunctiva, orbit, lacrimal gland, or lacrimal sac were grouped into conjunctival lymphoma and "orbital-type" lymphoma (i.e., orbit, lacrimal gland, and lacrimal sac). Subjects were investigated for morphological changes in meibomian glands by meiboscore grading system. Radiation technique was examined and Ocular Surface Disease Index (OSDI) questionnaire, Schirmer's test, tear film break-up time (TBUT), slit lamp examination of corneal surface and lid margin abnormality were conducted before and after RT.
The increase in meiboscore was statistically significant over time after RT in both groups (P < 0.001). The extent of increase in meiboscore was significantly greater in the "orbital-type" lymphoma group than in the conjunctival lymphoma group (P < 0.001). The changes in OSDI, TBUT, corneal fluorescein staining score and lid margin abnormality score after RT were significantly different across two groups (P = 0.042, 0.001, 0.035 and 0.001, respectively). Schirmer's value decreased after RT in both groups. Dry eye symptoms were most severe right after RT in both groups, but a gradual resolution was noted in most patients with conjunctival lymphoma, whereas symptoms persisted in "orbital-type" lymphoma patients. The OSDI score and corneal fluorescein staining score were positively correlated with meiboscore in "orbital-type" patients at post-RT 6 months (r = 0.43, P = 0.04; r = 0.39, P = 0.03, respectively).
Patients with OAML had different degrees of morphological changes in meibomian glands according to tumor location and radiation technique. "Orbital-type" lymphoma patients are more likely to experience severe injury to meibomian glands, which eventually leads to persistent dry eye. Patients with "orbital-type" lymphoma should be well informed of post-RT damage on meibomian glands and persistent dry eye.
放射治疗(RT)是治疗低级别眼附属器黏膜相关淋巴组织淋巴瘤(OAML)的首选方法,其中许多患者在治疗后会出现不同严重程度的干眼。本研究的目的是通过直接观察结构变化来研究 RT 对睑板腺和干眼的眼部影响。其次,我们根据肿瘤位置和放射技术将两组患者进行了比较。
将 64 只患有结膜、眼眶、泪腺或泪囊 OAML 的眼睛分为结膜淋巴瘤和“眼眶型”淋巴瘤(即眼眶、泪腺和泪囊)。通过睑板腺评分系统评估受试者的睑板腺形态学变化。检查放射技术,在 RT 前后进行眼表面疾病指数(OSDI)问卷、泪液分泌试验、泪膜破裂时间(TBUT)、角膜表面和眼睑边缘异常的裂隙灯检查。
两组患者 RT 后睑板腺评分均随时间呈统计学显著增加(P<0.001)。“眼眶型”淋巴瘤组的睑板腺评分增加幅度明显大于结膜淋巴瘤组(P<0.001)。RT 后 OSDI、TBUT、角膜荧光素染色评分和眼睑边缘异常评分在两组间的变化均有显著差异(P=0.042、0.001、0.035 和 0.001)。两组患者 RT 后 Schirmer 值均降低。两组患者干眼症状在 RT 后即刻最严重,但结膜淋巴瘤患者逐渐缓解,而“眼眶型”淋巴瘤患者症状持续存在。在 RT 后 6 个月,“眼眶型”患者的 OSDI 评分和角膜荧光素染色评分与睑板腺评分呈正相关(r=0.43,P=0.04;r=0.39,P=0.03)。
根据肿瘤位置和放射技术,OAML 患者的睑板腺形态学变化程度不同。“眼眶型”淋巴瘤患者更有可能发生严重的睑板腺损伤,最终导致持续的干眼。“眼眶型”淋巴瘤患者应充分了解 RT 对睑板腺的损害和持续的干眼。